# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-19-000041
Filing Date
2019-02-28
Accepted
2019-02-28 16:24:01
Documents
84
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | lgnd-20181231.htm iXBRL | 10-K | 3948653
2 |  | lgnd123118exhibit1048-.htm | EX-10.48 | 347129
3 |  | lgnd123118exhibit211-n.htm | EX-21.1 | 23780
4 |  | lgnd123118exhibit231-n.htm | EX-23.1 | 5984
5 |  | lgnd123118exhibit311-n.htm | EX-31.1 | 20545
6 |  | lgnd123118exhibit312-n.htm | EX-31.2 | 20294
7 |  | lgnd123118exhibit321-n.htm | EX-32.1 | 17804
13 |  | lgnd-20181231_g1.gif | GRAPHIC | 3925
14 |  | lgnd-20181231_g2.jpg | GRAPHIC | 113635
| Complete submission text file | 0000886163-19-000041.txt |  | 14907940

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20181231.xsd | EX-101.SCH | 73130
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20181231_cal.xml | EX-101.CAL | 147942
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20181231_def.xml | EX-101.DEF | 493307
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20181231_lab.xml | EX-101.LAB | 1035727
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20181231_pre.xml | EX-101.PRE | 667095
15 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20181231_htm.xml | XML | 2606873

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 19643635
SIC: 2834 Pharmaceutical Preparations